Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism

Aya Saiki1, Michio Otsuki1, Daisuke Tamada1

  • 1Department of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Insights

Diabetes Mellitus (DM) increases cardiovascular and renal risks in Primary Aldosteronism (PA) patients. Managing DM is crucial for better outcomes in this population.

Area of Science:

  • Endocrinology
  • Nephrology
  • Cardiology

Background:

  • Primary aldosteronism (PA) patients have a higher prevalence of diabetes mellitus (DM) compared to essential hypertension and general populations.
  • DM is a significant risk factor for cardio-cerebrovascular (CCV) diseases and renal complications, but its specific impact in PA remains unclear.

Purpose of the Study:

  • To investigate the influence of coexistent DM on the risk of CCV events.
  • To assess the effect of DM on the progression of renal complications in PA patients.

Main Methods:

  • A multi-institutional, cross-sectional study enrolled 2524 PA patients from the Japan PA registry (2006-2016).
  • Patients were categorized into DM and non-DM groups.
  • Logistic and linear regression analyses compared CCV events and renal complications between the groups.

Main Results:

  • DM significantly elevated the odds of CCV events (OR 1.59) and proteinuria (OR 2.25).
  • DM showed a significant correlation with declining estimated glomerular filtration rate (β = .05, P = .02).

Conclusions:

  • This study identifies DM as an independent risk factor for CCV events and renal complications in PA patients.
  • Integrated management of DM alongside PA treatment is recommended for improved patient outcomes.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
816
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
1.8K
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
2.7K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.1K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.1K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
732